Clinical guidelines released by public health organizations in developed countries and regions, such as the American Urological Association, Canadian Task Force on Prevention Health Care, Japanese Urological Association, and European Association of Urology, provided more accurate prostate cancer screening recommendations suggesting that men at an average risk, over certain years of age, with long life expectancy decide about PSA testing [16]. This evidence concerns the gene KLK3 and Familial prostate cancer.